Diagnóstico y tratamiento de las alteraciones oseominerales asociadas a la enfermedad renal crónica

Selective activators of vitamin D receptor, such as paricalcitol, affect vascular calcifications differently from calcitriol, and have also been associated with increased survival in patients with CKD. Calcimimetics are highly useful for achieving the traditional goals of treatment guidelines and their long-term results are currently being evaluated in several ongoing prospective studies.Thus, although the various treatments of CKD-MBD should ideally be evaluated prospectively, the combination of several drugs can reasonably be considered to be superior to monotherapy.